SCHEMBL31555348

SCHEMBL31555348

O=C(O)c1ccccc1Nc1ccc(Nc2ccc(C34CC5CC(CC(C5)C3)C4)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 2/20 0.60
▸ EPAS1 Q99814 2/20 0.60
▸ EPHX2 P34913 4/20 0.54
▸ FABP4 P15090 1/20 0.54
▸ NPC1 O15118 1/20 0.51
▸ PTGS1 P23219 1/20 0.50
▸ AKR1C3 P42330 1/20 0.50
▸ AKR1C2 P52895 1/20 0.50
▸ SERPINE1 P05121 2/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ TEAD4 Q15561 1/20 0.47
▸ TTR P02766 1/20 0.44
▸ RECQL P46063 1/20 0.43
▸ BLM P54132 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22452498 1.00 HIF1A (0.60) HIF1AEPAS1EPHX2FABP4NPC1
SCHEMBL22452502 0.94 HIF1A (0.54) HIF1AEPAS1EPHX2FABP4NPC1
SCHEMBL22453247 0.93 EPHX2 (0.65) HIF1AEPAS1EPHX2FABP4NPC1
SCHEMBL22452485 0.91 EPHX2 (0.52) HIF1AEPAS1EPHX2FABP4NPC1
SCHEMBL22452850 0.91 HIF1A (0.52) HIF1AEPAS1EPHX2FABP4NPC1
SCHEMBL22453497 0.90 SERPINE1 (0.57) HIF1AEPAS1EPHX2FABP4NPC1
SCHEMBL22452810 0.90 HIF1A (0.53) HIF1AEPAS1EPHX2FABP4NPC1
SCHEMBL22452527 0.90 SERPINE1 (0.57) HIF1AEPAS1EPHX2FABP4NPC1
SCHEMBL22453511 0.89 HIF1A (0.54) HIF1AEPAS1EPHX2FABP4NPC1
SCHEMBL22452488 0.88 SERPINE1 (0.64) HIF1AEPAS1EPHX2NPC1SERPINE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250122194-A1 NOVEL SMALL MOLECULE INHIBITORS OF TEAD TRANSCRIPTION FACTORS THE GENERAL HOSPITAL CORPORATION 2025-04-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122194-A1 NOVEL SMALL MOLECULE INHIBITORS OF TEAD TRANSCRIPTION FACTORS TEAD1, TEAD2, TEAD3 HIF1A 668/4885EPAS1 285/4885EPHX2 3663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback